REFERENCES
Bruning, A. H. L., Leeflang, M. M. G., Vos, J. M. B. W., Spijker, R., de
Jong, M. D., Wolthers, K. C., & Pajkrt, D. (2017). Rapid tests for
influenza, respiratory syncytial virus, and other respiratory viruses: a
systematic review and meta-analysis. Clinical Infectious
Diseases , 65 (6), 1026–1032. https://doi.org/1032.
doi:10.1093/cid/cix461
CDC. (2003a). CDC Lab Sequences Genome of New Coronavirus. CDC
Media Relations Press Release404-639-3286 .
/https://www.cdc.gov/media/pressrel/r030414.htm
CDC. (2003b). SARS-Associated Coronavirus (SARS-CoV) Sequencing.Laboratory Testing & Specimens .
https://www.cdc.gov/sars/lab/sequence.html
CDC. (2017). Severe Acute Respiratory Syndrome (SARS). National
Center for Immunization and Respiratory Diseases, Division of Viral
Diseases , 1 (1), 1–3.
CDC. (2020). Interim Guidelines for Collecting, Handling, and Testing
Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19).Coronavirus Disease 2019 (COVID-19) , 1–3.
https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html
Chan, P. K. S., To, W. K., Ng, K. C., Lam, R. K. Y., Ng, T. K., Chan, R.
C. W., Wu, A., Yu, W. C., Lee, N., Hui, D. S. C., Lai, S. T., Hon, E. K.
L., Li, C. K., Sung, J. J. Y., & Tam, J. S. (2004). Laboratory
Diagnosis of SARS. Emerging Infectious Diseases , 10 (5),
825–831. https://doi.org/10.3201/eid1005.030682
Cheng, M. P., Papenburg, J., Desjardins, M., Kanjilal, S., Quach, C.,
Libman, M., Dittrich, S., Yansouni, C. P. (2020). Diagnostic Testing for
Severe Acute Respiratory Syndrome–Related Coronavirus-2: A Narrative
Review. Annals of Internal Medicine Logo , 1 (1), 1–10.
Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D.
K. & Mulders, D. G. (2020). Detection of 2019 novel coronavirus
(2019-nCoV) by real-time RT-PCR. Eurosurveillance , 25 (3),
2000045.
David, A.J.T and Steven, H. M. (1996). Medical
Microbiology.Coronaviruses (4th ed.). he University of Texas Medical
Branch at Galveston. https://www.ncbi.nlm.nih.gov/books/NBK7782/
Dembert, M. L., & Kaiser, C. (1983). Laboratory diagnosis of viral
infections. American Family Physician , 28 (4), 125–139.
https://doi.org/10.1016/b978-0-12-800946-8.00005-2
ECDC. (2020a). COVID-19 situation update worldwide, as of 8 May 2020.Threats and Outbreaks Situation Update Worldwide .
https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases
ECDC. (2020b). Novel coronavirus (SARS-CoV-2) Discharge criteria for
confirmed COVID-19 cases – When is it safe to discharge COVID-19 cases
from the hospital or end home isolation? ECDC Technical Report ,
1–5.
https://www.nejm.org/doi/pdf/10.1056/NEJMc2001468?articleTools=true
Elflein, J. (2020). Coronavirus (COVID-19) disease pandemic- Statistics
& Facts. Health & Pharmaceuticals›State of Health .
https://www.statista.com/topics/5994/the-coronavirus-disease-covid-19-outbreak/
FDA. (2020). Immediately in Effect Guidance for Clinical Laboratories,
Commercial Manufacturers, and Food and Drug Administration Staff.Policy for Diagnostic Tests for Coronavirus Disease-2019 during
the Public Health Emergency , 1 (1), 1–10.
Fuk-Woo, J. C., Yuan, S., Kok, K., Kai-Wang, K.To., Chu, H., Yang, J.,
Xing, F., Liu, J., Chik-Yan, C.Y., Wing-Shan, R.P., Tsoi, H., Kam-Fai,
S.L, Chan, K., Kwok-Man, V.P., Chan, J., DanieL., J.I., Cai, Chi-Chung,
V.C., Chen, H., Christopher, K., Yuen, K. (2020). A familial cluster of
pneumonia associated with the 2019 novel coronavirus indicating
person-to-person transmission: a study of a family cluster. The
Lancet, Elseveir Articles , 395 (10229), 1054. www.thelancet.com
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan,
G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie,
X., Yin, W., Li, H., Liu, M., … Cao, B. (2020). Clinical features
of patients infected with 2019 novel coronavirus in Wuhan, China.The Lancet , 395 (10223), 497–506.
https://doi.org/10.1016/S0140-6736(20)30183-5
Hui, D. S. C., Chan, M. C. H., Wu, A. K., & Ng, P. C. (2004). Severe
acute respiratory syndrome (SARS): Epidemiology and clinical features.Postgraduate Medical Journal , 80 (945), 373–381.
https://doi.org/10.1136/pgmj.2004.020263
James, N. (2017). Fenner’s veterinary virology. In Elsevier
Academic Press. https://doi.org/0.1016/b978-0-12-800946-8.00005-2
Kang, X., Xu, Y., Wu, X., Liang, Y., Wang, C., Guo, J., Wang, Y., Chen,
M., Wu, D., Wang, Y., Bi, S., Qiu, Y., Lu, P., Cheng, J., Xiao, B., Hu,
L., Gao, X., Liu, J., Wang, Y., … Tang, H. (2005). Proteomic
fingerprints for potential application to early diagnosis of severe
acute respiratory syndrome. Clinical Chemistry , 51 (1),
56–64. https://doi.org/10.1373/clinchem.2004.032458
Lau, S. K. P., Woo, P. C. Y., Wong, B. H. L., Tsoi, H. W., Woo, G. K.
S., Poon, R. W. S., Chan, K. H., Wei, W. I., Malik Peiris, J. S., &
Yuen, K. Y. (2004). Detection of severe acute respiratory syndrome
(SARS) coronavirus nucleocapsid protein in SARS patients by
enzyme-linked immunosorbent assay. Journal of Clinical
Microbiology , 42 (7), 2884–2889.
https://doi.org/10.1128/JCM.42.7.2884-2889.2004
Leung, D. T. M., Tam, F. C. H., Ma, C. H., Chan, P. K. S., Cheung, J. L.
K., Niu, H., Tam, J. S. L., & Lim, P. L. (2004). Antibody Response of
Patients with Severe Acute Respiratory Syndrome (SARS) Targets the Viral
Nucleocapsid. The Journal of Infectious Diseases , 190 (2),
379–386. https://doi.org/10.1086/422040
Li, Z., Yi, Y., Luo, X., Xiong, N., Liu, Y., Li, S., Sun, R., Wang, Y.,
Hu, B., Chen, W., Zhang, Y., Wang, J., Huang, B., Lin, Y., Yang, J.,
Cai, W., Wang, X., Cheng, J., Chen, Z., … Ye, F. (2020).
Development and clinical application of a rapid IgM-IgG combined
antibody test for SARS-CoV-2 infection diagnosis. Journal of
Medical Virology , 0–1. https://doi.org/10.1002/jmv.25727
Maschinen, B., Investition, A., Beschaffungen, G., Ersatzbeschaffungen,
B., & Mittelherkunft, S. (2005). Distric laboratory practice in
tropical countries .
McIntosh, Kenneth., Martin S Hirsch., A. B. (2020). Coronavirus disease
2019 (COVID-19): Epidemiology, virology, clinical features, diagnosis,
and prevention. 2020Uptodate , 1 (1).
https://www.uptodate.com/contents/coronavirus-disease-2019
NIM. (2020). COVID-19 is an emerging, rapidly evolving situation.National Institute for Allergy and Infectious Diseasdes .
https://www.niaid.nih.gov/diseases-conditions/coronaviruses
Okba, N. M. A., Muller, M. A., Li, W., Wang, C., GeurtsvanKessel, C. H.,
Corman, V. M., Lamers, M. M., Sikkema, R. S., Bruin, E. de, Chandler, F.
D., Yazdanpanah, Y., Hingrat, Q. Le, Descamps, D., Houhou-Fidouh, N.,
Reusken, C. B. E. M., Bosch, B.-J., Drosten, C., Koopmans, M. P. G., &
Haagmans, B. L. (2020). SARS-CoV-2 specific antibody responses in
COVID-19 patients. MedRxiv , 2020.03.18.20038059.
https://doi.org/10.1101/2020.03.18.20038059
Reller, L. B., & Weinstein, M. P. (2000). Special section: Medical
microbiology. Clinical Infectious Diseases , 30 (5), 798.
https://doi.org/10.1086/313790
Ren, Y., He, Q. Y., Fan, J., Jones, B., Zhou, Y., Xie, Y., Cheung, C.
Y., Wu, A., Chiu, J. F., Peiris, J. S. M., & Tam, P. K. H. (2004). The
use of proteomics in the discovery of serum biomarkers from patients
with severe acute respiratory syndrome. Proteomics , 4 (11),
3477–3484. https://doi.org/10.1002/pmic.200400897
Roos, R. (2003). WHO cites limitations of SARS diagnostic tests.Center for Infectious Diseases and Polycies , 1 (1).
Sampathkumar, P., Temesgen, Z., Smith, T. F., & Thompson, R. L. (2003).
SARS: Epidemiology, clinical presentation, management, and infection
control measures. Mayo Clinic Proceedings , 78 (7),
882–890. https://doi.org/10.4065/78.7.882
Sheridan, C. (2020). Fast, portable tests come online to curb
coronavirus pandemic. Naturenature Biotechnologynewsarticle a
Nature Research Journal , 2020 (1–10).
https://www.nature.com/articles/d41587-020-00010-2
USFDA. (2020). FAQs on Diagnostic Testing for SARS-CoV-2. An
Official Website of the United States Governmen , 1–2.
https://www.fda.gov/medical-devices/emergency-situations-medical-devices/faqs
Vashist, S. K. (2017). Point-of-care diagnostics: Recent advances and
trends. Biosensors , 7 (4), 10–13.
https://doi.org/10.3390/bios7040062
Wadsworth, N. (2003). Laboratory Diagnosis of SARS . 1–13.
https://www.health.ny.gov/diseases/communicable/sars
WHO. (2003). Consensus document on the epidemiology of severe acute
respiratory syndrome (SARS). Consensus Document on the
Epidemiology of Severe Acute Respiratory Syndrome (SARS) , 1–47.
https://www.who.int/csr/sars/en/WHOconsensus.pdf
WHO. (2020). Coronavirus disease (COVID-19) Pandemic. Coronavirus
Disease 2019 .
https://www.who.int/emergencies/diseases/novel-coronavirus-2019?
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang,
L., Zhou, X., Du, C., Zhang, Y., Song, J., Wang, S., Chao, Y., Yang, Z.,
Xu, J., Zhou, X., Chen, D., Xiong, W., Xu, L., Zhou, F., Jiang, J., Ba,
i C., Zheng, J., Song, Y. (2020). Risk Factors Associated With Acute
Respiratory Distress Syndrome and Death in Patients With Coronavirus
Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. ,2020 . oi: 10.1001/jamainternmed.2020.0994.
Xu, X. (2020). SARS-CoV-2 (2019-nCoV) Antigen Reagents. Evolution
of the novel coronavirus from the ongoing Wuhan outbreak and modeling of
its spike protein for risk of human transmission .
https://www.sinobiological.com/research/virus/2019-ncov-antigen
Ying, L., Yue-ping, L., Bo, D., Feifei, R., Yue, W., Jinya, D.,
Qianchuan, H., Hospital, G., Command, C. T., Hospital, G., & Theater,
C. (2020). Diagnostic Indexes of a Rapid IgG/IgM Combined Antibody
Test for SARS-CoV-2 . 1–14.
Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan,
J., Li, T., Li, J., Qian, S., Hong, C., Wang, F., Liu, Y., Wang, Z., He,
Q., Li, Z., He, B., Zhang, T., … Zhang, Z. (2020). Antibody
responses to SARS-CoV-2 in patients of novel coronavirus disease 2019.Clinical Infectious Diseases : An Official Publication of the
Infectious Diseases Society of America .
https://doi.org/10.1093/cid/ciaa344